Needham & Company
View Older Stories
-
G1 Therapeutics Announces Closing of Offering of Common Stock
-
G1 Therapeutics Announces Closing of Offering of Common Stock
-
G1 Therapeutics (GTHX) Prices 7.7M Share Offering at $6.50/sh
-
G1 Therapeutics Announces Pricing of Offering of Common Stock
-
G1 Therapeutics Announces Pricing of Offering of Common Stock
-
G1 Therapeutics (GTHX) PT Lowered to $42 at Needham & Company
-
Needham & Company Reiterates Buy Rating, $44 Price Target on G1 Therapeutics (GTHX)
-
G1 Therapeutics to Participate in the 21st Annual Needham Virtual Healthcare Conference
-
G1 Therapeutics to Present at the 20th Annual Needham Virtual Healthcare Conference
-
G1 Therapeutics to Present at 19th Annual Needham Virtual Healthcare Conference on April 14, 2020
-
G1 Therapeutics to Present at the 18th Annual Needham Healthcare Conference
-
G1 Therapeutics to Present at the 18th Annual Needham Healthcare Conference
-
Pre-Open Stock Movers 12/20: (AGEN) (TLRY) (PTE) Higher; (DBVT) (ADMA) (SPPI) Lower (more...)
-
G1 Therapeutics (GTHX) PT Lowered to $74 at Needham & Company
-
G1 Therapeutics Announces Closing of Offering of Common Stock
-
G1 Therapeutics Announces Closing of Offering of Common Stock
-
G1 Therapeutics (GTHX) Prices 3M Share Common Offering at $60/Sh
-
G1 Therapeutics Announces Pricing of Offering of Common Stock
-
G1 Therapeutics Announces Pricing of Offering of Common Stock
-
G1 Therapeutics (GTHX) PT Raised to $76 at Needham & Company as Protocol Amendment
-
Needham & Company Reiterates Buy on G1 Therapeutics
-
G1 Therapeutics (GTHX) PT Raised to $60 at Needham & Company; 'Early G1T38 Data Consistent with Best-in-Class Profile'
-
G1 Therapeutics (GTHX) PT Raised to $42 at Needham & Company
-
G1 Therapeutics Announces Closing of Offering of Common Stock
-
G1 Therapeutics Announces Closing of Offering of Common Stock
-
G1 Therapeutics (GTHX) Prices 3.4M Shares at $29.50
-
G1 Therapeutics Announces Pricing of Offering of Common Stock
-
G1 Therapeutics Announces Pricing of Offering of Common Stock
-
Pre-Open Movers 03/06: (AMDA) (CLBS) (GNCA) Higher; (GLYC) (FRPT) (ASNA) Lower (more...)
-
G1 Therapeutics to Present at Investor Conferences in March 2018
-
G1 Therapeutics to Present at Investor Conferences in March 2018
-
Needham & Company Starts G1 Therapeutics (GTHX) at Buy; Unique and Best-in-Class Oncology Drug Development
-
Needham & Company Starts G1 Therapeutics (GTHX) at Buy
-
G1 Therapeutics Announces Closing of Initial Public Offering
-
G1 Therapeutics (GTHX) IPO Opens Flat
-
G1 Therapeutics (GTHX) IPO Prices at $15
-
G1 Therapeutics Announces Pricing of Initial Public Offering
-
G1 Therapeutics Announces Launch of Initial Public Offering